The Intuitive Surgical DA VINCI ROBOT
In recent years, DA VINCI has become a must for fellow surgeons in the most advanced centers around the world. This robot has indeed led to a revolution in operating theaters, particularly in the field of urologic surgery and particularly in the surgical treatment of prostate cancer.
DA VINCI was not born in Tuscany, but in 2000 in Silicon Valley California. With four articulated arms, a 3D binocular camera, the DA Vinci robot allows a range of wrist movements of 180 degrees unequaled to man. In addition it can carry out movements of great precision: all little errors caused by spasms for instance, are deleted. It finds its best indication with radical prostatectomy accompanied by a computer which ensures high accuracy of the surgical procedure, particularly desirable in this procedure for the dissection of very fine structures ensuring urinary continence and preservation of sexuality. Despite its great qualities, DA VINCI needs to be directed by a surgeon in the flesh. This collaboration between man and robot in regards to operating on prostate cancer, without a doubt enables much postoperative pain to be avoided.
Dr. DAVODY speaks on his own behalf and receives no sponsorship from the INTUITIVE SURGICAL Company.
Most common cancer in men, prostate cancer is usually slow-growing but potentially deadly and never shows symptoms when it is curable. It is a major health problem, of particular concern for men over 45, but also effects economically society as a whole. To find out more
Genital prolapse or rather in common terms “the falling of organs” in women. Is a static disorder of the female pelvis rarely life threatening, but can often be the cause of major discomfort. To find out more
Observed nearly 10 times less often than prostate cancer, kidney cancer still represents a significant problem because of its frequency and severity. To find out more
Family history is known to be a factor in increased risk of prostate cancer. Two or more first-degree relatives (father, brother or son) with the disease will increase a patient’s risk of contracting prostate cancer.